But it's still one listed entity, which is the crux of it. Imagine we get a slam dunk with the vaccine, billions of dollars to sell it. We won't be able to use that money on the regen business, and the tax implications of a dividend wouldn't likely be better than a takeover (only CGT to pay). Therefore two listed entities are better than one. But maybe they're planning for it down the road.
More on cormatrix, page-12
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.25 |
Change
-0.750(5.00%) |
Mkt cap ! $305.4M | |||
| Open | High | Low | Value | Volume |
| $14.50 | $14.50 | $14.25 | $224.3K | 15.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 26 | $14.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.44 | 274 | 3 |
View Market Depth
| Last trade - 10.52am 05/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |